Coronary Plaque Formation: Stop the Heart's Silent Killer

What Is Coronary Plaque?

Coronary plaque is an abnormal accumulation of cholesterol, oxidised lipids, inflammatory cells, calcium deposits, and fibrous tissue within the coronary artery intima, which progressively narrows the arterial lumen and restricts blood flow to the heart muscle over years to decades.

Coronary atherosclerosis drives plaque formation silently; most patients remain asymptomatic until arterial stenosis exceeds 70% or plaque ruptures, triggering acute thrombosis. Plaques are classified into two clinically distinct types: calcified plaques, which are stable and less prone to rupture, and non-calcified plaques, which contain a lipid-rich core covered by a thin fibrous cap, making them vulnerable to sudden rupture. Research across 30,154 asymptomatic individuals in the SCAPIS study demonstrated that 42% of the general population aged 50-64 carries detectable coronary plaque on CCTA imaging without any cardiac symptoms ^[1]. Non-calcified plaque represents the higher-risk subtype, as rupture triggers acute coronary syndromes accounting for most sudden cardiac deaths.

Also read: 128-Slice Cardiac CT Scan: An Informational Guide.

How Coronary Plaque Forms

Coronary plaque formation follows a predictable multistage pathological sequence driven by endothelial dysfunction, lipid accumulation, chronic inflammation, and progressive fibrous cap destabilisation occurring silently over decades.

Here is a stepwise process for coronary plaque formation:

Step 1: Endothelial Injury

Hypertension, smoking, diabetes, and elevated LDL damage the coronary artery endothelium, increasing its permeability to circulating lipoproteins. Damaged endothelium expresses adhesion molecules, thereby recruiting inflammatory monocytes into the arterial intima and initiating the atherosclerotic process.

Step 2: Foam Cell Formation

Monocytes differentiate into macrophages that engulf oxidised LDL, transforming into lipid-laden foam cells and creating the earliest visible lesion, called a fatty streak. This stage remains potentially reversible with aggressive risk factor modification and LDL reduction.

Step 3: Fibrous Cap Development

Smooth muscle cells migrate into the intima, forming a fibrous collagen cap over the expanding lipid-rich necrotic core. As the plaque enlarges, the coronary arterial lumen progressively narrows, restricting blood flow and producing stable angina during exertion.

Step 4: Cap Thinning

Matrix metalloproteinases released by inflammatory macrophages degrade fibrous cap collagen, thereby reducing cap thickness below the critical 65 µm threshold that defines thin-cap fibroatheroma (TCFA). Plaques with caps thinner than 65 µm carry the highest risk of rupture, regardless of stenosis severity.

Step 5: Plaque Rupture

TCFA rupture exposes the thrombogenic lipid core to circulating blood, triggering acute platelet aggregation and thrombus formation. Plaque rupture accounts for up to 75% of all acute coronary syndromes, including heart attacks and sudden cardiac death ^[2].

Risk Factors and Warning Signs of Blocked Arteries

Coronary plaque builds silently for decades, making risk factor identification and symptom recognition the only reliable strategy for preventing life-threatening blocked arteries before a cardiac emergency occurs.

Here are five risk factors and warning signs that lead to blocked arteries:

1. Lifestyle Risk Factors

Smoking, poor diet high in saturated fats, physical inactivity, and excessive alcohol directly accelerate coronary atherosclerosis progression. Almost one-third of all coronary heart disease deaths are directly linked to smoking or secondhand smoke exposure.

2. Medical Risk Factors

Uncontrolled hypertension, diabetes, and high LDL cholesterol create the internal arterial environment where coronary plaque deposits and grows. Diabetic patients face compounded risk because elevated blood glucose simultaneously damages the endothelium and accelerates lipid oxidation within the artery walls.

3. Who Is Most Vulnerable

Men above 45, women above 55, and anyone with a first-degree relative diagnosed with early coronary artery disease carry significantly elevated plaque risk. Adults above 40 carry approximately 50% lifetime risk of developing significant coronary atherosclerosis regardless of apparent good health.

4. Symptoms You Should Not Ignore

Chest tightness during exertion, unexplained breathlessness, jaw pain, left arm heaviness, and persistent fatigue signal hemodynamically significant blocked arteries requiring immediate clinical assessment. Diabetic patients frequently experience no chest pain despite severe stenosis due to autonomic neuropathy masking ischemia.

5. Emergency Red Flags

Crushing chest pain at rest, cold sweats, nausea, and sudden breathlessness indicate acute plaque rupture requiring emergency atherosclerosis treatment within 90 minutes. Delay beyond this window causes irreversible myocardial damage directly proportional to treatment delay duration.

Detecting Coronary Plaque: The Role of CT Angiography

Coronary CT angiography (CCTA) is the only non-invasive imaging modality capable of directly visualising coronary plaque burden, characterising plaque composition, and identifying high-risk features before clinical symptoms develop.

Here are some data-backed considerations that define the role of a CT angiogram for coronary plaque detection:

• CCTA identifies calcified, non-calcified, and mixed coronary plaque within arterial walls, measures stenosis severity, and characterises high-risk plaque features, including low-attenuation plaque, positive remodelling, and thin fibrous caps. Research demonstrates that CCTA achieves 93% overall accuracy, 91% sensitivity, and 98% specificity for coronary plaque detection, with optical coherence tomography as standard.
• CCTA differentiates stable calcified plaque from rupture-prone non-calcified plaque, enabling risk-stratified treatment decisions before blocked arteries cause symptoms. Non-calcified plaque identification through CCTA directly guides intensification of atherosclerosis treatment in high-risk patients.
• Calcium scoring (CAC) provides initial plaque burden quantification without contrast injection, stratifying patients into low, intermediate, and high cardiovascular risk categories for further investigation.
  CCTA requires only an intravenous contrast injection without catheter insertion, is completed in under 30 minutes, and provides immediate plaque characterisation unavailable through conventional invasive angiography.
• Intermediate-risk patients with chest pain, strong family history, diabetes with cardiac symptoms, and inconclusive stress test results benefit most from CCTA for definitive coronary plaque assessment and treatment planning.

Also read: Silent MRI Scans: The Best Solution for Claustrophobia.

Atherosclerosis Treatment: How to Reduce Plaque in Arteries

Effective atherosclerosis treatment combines lifestyle modification, pharmacotherapy, and interventional procedures, based on plaque severity as confirmed by CT angiography, cardiac imaging, and clinical risk assessment. Statin therapy is the most evidence-based approach to reducing arterial plaque; a meta-analysis of 17 studies involving 2,171 patients demonstrated that statins significantly reduced plaque volume by 5.3 mm³ while stabilising vulnerable non-calcified plaques prone to rupture ^[3].

Mediterranean diet adherence, 150 minutes of weekly aerobic exercise, smoking cessation, and blood pressure control below 130/80 mmHg complement pharmacotherapy by addressing endothelial injury mechanisms that drive plaque progression. For blocked arteries with stenosis exceeding 70%, percutaneous coronary intervention with stenting restores blood flow; multi-vessel disease requires coronary artery bypass grafting. Serial CT angiography of the heart monitors the treatment response to atherosclerosis, detecting plaque regression or progression before symptoms develop.

CT Angiography at Eskag Sanjeevani

Cardiovascular diseases account for 28.1% of total deaths in India, making accessible cardiac CT imaging a clinical necessity ^[4]. Eskag Sanjeevani Radiology’s 128-Slice Cardiac CT captures 128 image slices per rotation with scan times as low as 0.35 seconds. It eliminates cardiac motion artefacts that compromise the accuracy of coronary plaque characterisation in standard CT systems. The scanner’s 16cm per-rotation coverage area enables complete cardiac and coronary artery imaging in seconds, significantly reducing scan duration for patients with arrhythmias or difficulty breathing.

Advanced dose-reduction protocols and motion-correction technology deliver high-resolution coronary plaque imaging at minimum radiation exposure, making the procedure appropriate for repeated surveillance scanning in high-risk patients. Iterative reconstruction software generates multiplanar 3D renderings, allowing radiologists to assess calcified and noncalcified plaque, stenosis severity, valve disorders, bypass grafts, and stent patency from a single acquisition.